Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityFrédéric Rieux‐Laucat, Jean‐Pierre de Villartay, Claire Hivroz et al.|Science|1995Cited by 1.3k
Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycinSelim Corbacioglu, Klaus‐Michael Debatin|Blood|2006Cited by 72
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signalingGudrun Strauß, Klaus‐Michael Debatin|The Journal of Experimental Medicine|2009Cited by 47
Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expressionMarkus D. Herrmann, Klaus‐Michael Debatin|Experimental Hematology|2013Cited by 12
Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclaxAlexandra Niedermayer, Klaus‐Michael Debatin|Leukemia|2025Cited by 4